Influenza - Pipeline Review

 Summary

 Global Markets Direct, Influenza - Pipeline Review, H2 2011, {provides an|has an|offers an} {overview of|summary of|breakdown of|introduction to|review of} the Influenza therapeutic pipeline. This report provides {information on|home elevators|info on|home|house elevators} the therapeutic development for Influenza, {complete with|filled with|detailed with|full of|that includes} latest updates, and special features on late-stage and discontinued projects. {It also|Additionally , it|In addition , it|What's more , it|Furthermore , it} reviews key players {involved in the|active in the|mixed up in} therapeutic development for Influenza. Influenza - Pipeline Review, H2 2011 {is built|is made|is created|was made} using data and information sourced from Global Markets Direct proprietary databases, Company/University websites, SEC filings, investor presentations and featured {press releases|press announcements|pr announcements|pr releases|press announcments} from company/university sites and industry-specific {third party|3rd party|alternative party|vacation|alternative} sources, {put together|come up with|assembled|build|created|assemble} by Global Markets Direct team.

 Note*: Certain sections {in the|within the|inside the|inside|from the} report {may be|might be|could be|could possibly be|can be} removed or altered {based on the|in line with the|good|using the|depending on the} availability and relevance {of data|of information|of knowledge|of internet data|of web data} {for the|for that|for your|to the|with the} indicated disease.

 Scope

 - A snapshot {of the|from the|with the|in the|on the} global therapeutic scenario for Influenza. - {A review of|Overview of|An assessment|Analysis|Examination} the Influenza products under development by companies and universities/research institutes {based on|depending on|according to|determined by|dependant on} information {derived from|based on|produced from|produced by|created from} company and industry-specific sources. - Coverage of products {based on|depending on|according to|determined by|dependant on} various stages of development {ranging from|which range from|including|starting from|between} discovery till registration stages. - {A feature|An element|An attribute} on pipeline projects {on the basis of|based on|on such basis as|judging by|by} monotherapy and combined therapeutics. - Coverage {of the|from the|with the|in the|on the} Influenza pipeline {on the basis of|based on|on such basis as|judging by|by} route of administration and molecule type. - Profiles {of late|recently|lately|late|latterly}-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals {relating to|associated with|concerning|in relation to|pertaining to} {the products|these products|the merchandise|the items|products}.

 {Reasons to|Good reasons to|Top reasons to|Why you should|Reasons why you should} buy

 - Identify and understand important and diverse {types of|kinds of|forms of|varieties of|sorts of} therapeutics under development for Influenza. - Identify emerging players with potentially strong product portfolio and design effective counter-{strategies to|ways of|ways to} gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players {with the most|most abundant in|with|with more} promising pipeline. - Devise corrective measures for pipeline projects by understanding Influenza pipeline depth {and focus|and concentrate|while focusing|while keeping focused|while keeping your focus} of Influenza therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners {with the most|most abundant in|with|with more} attractive projects {to enhance|to improve|to boost|to further improve|to reinforce} and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and {understanding the|comprehending the|knowing the|learning the|having the} factors that drove them from pipeline - Influenza - Pipeline Review